Cessatech is a Danish company active in the pharmaceutical industry. The company specializes in the research and development of analgesic nasal spray that is further used for the treatment of acute pain conditions among children. In addition to the main business, service and associated ancillary services are also offered. The business is run globally with the largest presence in the Nordic market.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Jes Trygved | 6,56 | 6,56 | 2022-12-31 |
| Steen Winther Henneberg | 3,63 | 3,63 | 2022-12-29 |
| Bettina Nygaard Nielsen | 3,63 | 3,63 | 2022-12-29 |
| Henriksen Group Aps | 2,80 | 2,80 | 2022-12-29 |
| Gainbridge Capital | 2,39 | 2,39 | 2023-04-30 |
| Adam Steensberg | 1,20 | 1,20 | 2022-12-31 |
| Charlotte Videbaek | 1,19 | 1,19 | 2022-12-31 |
| Martin Olin | 0,63 | 0,63 | 2022-12-31 |
| Peter Birk | 0,07 | 0,07 | 2022-12-31 |
2023-08-24 Delårsrapport 2023-Q2
2023-11-16 Delårsrapport 2023-Q3
2024-02-29 Bokslutskommuniké 2023